Get started
Author

Marta Maccallini

Observed names: M Maccallini, M. Maccallini
ORCID: 0009-0008-8593-2144
Observed ORCID: 0009-0008-8593-2144
OpenAlex ID: A5003977205
Guideline-Directed Medical Therapy in Severe Heart Failure with Reduced Ejection Fraction: An Analysis from the HELP-HF Registry
2023 · Daniela Tomasoni, Matteo Pagnesi, et al. · European Journal of Heart Failure · 59
PDF
Prognostic impact of the updated 2018 HFA‐ESC definition of advanced heart failure: results from the HELP‐HF registry
2022 · Matteo Pagnesi, Carlo Mario Lombardi, et al. · European Journal of Heart Failure · 50
PDF
Impact of Malnutrition in Patients with Severe Heart Failure
2024 · Matteo Pagnesi, Lisa Serafini, et al. · European Journal of Heart Failure · 42
PDF
Detailed Assessment of the “I Need Help” Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry
2023 · Matteo Pagnesi, Daniele Ghiraldin, et al. · Circulation Heart Failure · 33
PDF
Frailty According to the 2019 HFA-ESC Definition in Patients at Risk for Advanced Heart Failure: Insights from the HELP-HF Registry
2024 · Alessandro Villaschi, Mauro Chiarito, et al. · European Journal of Heart Failure · 28
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study
2021 · Alessandro Pizzocaro, Paolo Colombo, et al. · Endocrine · 22
PDF
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure
2024 · Matteo Pagnesi, Mauro Riccardi, et al. · Journal of Cardiovascular Medicine · 20
Prognostic role of mitral regurgitation in patients with advanced heart failure
2023 · Matteo Pagnesi, Filippo Calì, et al. · European Journal of Internal Medicine · 18
PDF
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry
2023 · Alessandro Villaschi, Matteo Pagnesi, et al. · The American Journal of Cardiology · 15
PDF
Role of Ejection Fraction in Patients at Risk for Advanced Heart Failure: Insights from the HELP-HF Registry
2023 · Matteo Pagnesi, Carlo Mario Lombardi, et al. · ESC Heart Failure · 13
PDF
OPTImal PHARMacological Therapy for Patients with Heart Failure: Rationale and Design of the OPTIPHARM-HF Registry
2024 · Riccardo M. Inciardi, Muthiah Vaduganathan, et al. · European Journal of Heart Failure · 12
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure
2023 · Matteo Pagnesi, Antonio Maria Sammartino, et al. · Journal of Cardiovascular Medicine · 10
Predicting Survival in Patients with Severe Heart Failure: Risk Score Validation in the HELP-HF Cohort
2025 · Mauro Chiarito, Davide Stolfo, et al. · European Journal of Heart Failure · 9
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure
2023 · Davide Stolfo, Matteo Pagnesi, et al. · The Journal of Heart and Lung Transplantation · 9
PDF
Contemporary Medical Therapy for Heart Failure Across the Ejection Fraction Spectrum: The OPTIPHARM-HF Registry
2025 · Riccardo M. Inciardi, Maurizio Volterrani, et al. · European Journal of Heart Failure · 7
Diuretic resistance in acute heart failure: proposal for a new urinary sodium-based definition
2024 · M. Pellegrino, A. Villaschi, et al. · International Journal of Cardiology · 6
Prognostic value of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in cardiac amyloidosis
2024 · Marta Maccallini, Gonzalo Barge-Caballero, et al. · Revista Española de Cardiología (English Edition) · 6
PDF
Valor pronóstico de la razón desplazamiento sistólico del plano del anillo tricuspídeo/presión arterial pulmonar sistólica en la amiloidosis cardiaca
2024 · Marta Maccallini, Gonzalo Barge-Caballero, et al. · Revista Española de Cardiología · 5
Use of SGLT2i in patients with transthyretin amyloid cardiomyopathy: prevalence and safety in a Spanish prospective cohort
2023 · Miguel González-Montes, Marta Maccallini, et al. · Revista Española de Cardiología (English Edition) · 3
Uso de iSGLT2 en pacientes con amiloidosis cardiaca por transtirretina: prevalencia y seguridad en una cohorte prospectiva en España
2023 · Miguel González-Montes, Marta Maccallini, et al. · Revista Española de Cardiología · 3
480 Catheter pulmonary vein ablation vs. medical therapy or atrioventricular node ablation and resynchronization in patients with atrial fibrillation and heart failure: a systematic review and meta-analysis
2021 · Gaetano Liccardo, Francesco Cannata, et al. · European Heart Journal Supplements · 2
PDF
Medical treatments at 6 months in hospitalized and ambulatory HFrEF patients in the BRING-UP 3 Heart Failure study
2026 · Fabrizio Oliva, Francesco Orso, et al. · ESC Heart Failure · 1
Clinical congestion patterns in patients with advanced heart failure: an analysis of the HELP-HF Registry
2026 · Mauro Riccardi, Gianmarco Cozzani, et al. · Journal of Cardiovascular Medicine
Cardio-kidney-metabolic overlap in patients with severe heart failure: Data from the HELP-HF registry
2026 · Alessandro Villaschi, Daniela Pini, et al. · American Heart Journal
Chronic intermittent levosimendan infusion as destination therapy in advanced heart failure: a single center experience
2026 · G Filiberti, M De Carli, et al. · European Journal of Heart Failure
Works count: 30
Citation count: 373
H-index: 11
I10-index: 12
Year
Topic
Type